Position in BNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,183,875
+$798,670 QoQ
Shares Held
12,723
+193.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#124
of 282 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $17,616,464 across 25 Biotechnology names. BNTX ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,027 | $4,483,981 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,135 | $3,108,383 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,385 | $1,538,593 | |
| 4 | EXEL |
Exelixis, Inc.
|
23,865 | $1,298,494 | |
| 5 | INCY |
Incyte Corp
|
10,863 | $1,231,429 | |
| 6 | BNTX |
BioNTech SE
This page
|
12,723 | $1,183,875 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,301 | $811,225 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,761 | $685,723 |
All Filings in BNTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,183,875 | 12,723 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $385,205 | 4,334 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||